Source-linked trial list

The registrations behind this number.

Verify the exact trial registrations behind a company, intervention, programme or topic count.

Exact trial list

5 matching trial registrations

Intervention bevacizumab
Topic Cancer and ageing

Showing 1–5 of 5. Every record below meets all the filters shown above.

Active Not RecruitingNCT03451370

First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer

Phase not reported · 121 planned enrolment

Countries listed: 1
Registry update: April 15, 2026

Verify in the registry →

UnknownNCT05273814

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

PHASE1 · 30 planned enrolment

Countries listed: 1
Registry update: July 13, 2022

Verify in the registry →

TerminatedNCT00351039

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

PHASE1 · PHASE2 · 8 planned enrolment

Countries listed: 1
Registry update: March 23, 2017

Verify in the registry →

CompletedNCT00484939

A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer

PHASE3 · 280 planned enrolment

Countries listed: 12
Registry update: January 8, 2015

Verify in the registry →

CompletedNCT01024504

Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer

PHASE2 · 46 planned enrolment

Countries listed: 1
Registry update: April 9, 2010

Verify in the registry →